PTD-Modified ATTEMPTS for Enhanced Toxin-based Cancer Therapy: An In Vivo Proof-of-Concept Study

PURPOSE: To investigate the feasibility of applying PTD-modified ATTEMPTS (Antibody Targeted Triggered Electrically Modified Prodrug-Type Strategy) for enhanced toxin therapy for the treatment of cancer. METHODS: A heparin-functionalized murine anti-CEA monoclonal antibody (mAb), T84.66-heparin (T84...

Ful tanımlama

Kaydedildi:
Detaylı Bibliyografya
Yayımlandı:Pharm Res
Asıl Yazarlar: Shin, Meong Cheol, Zhang, Jian, Min, Kyoung Ah, He, Huining, David, Allan E., Huang, Yongzhuo, Yang, Victor C.
Materyal Türü: Artigo
Dil:Inglês
Baskı/Yayın Bilgisi: 2015
Konular:
Article
Online Erişim:https://ncbi.nlm.nih.gov/pmc/articles/PMC4490053/
https://ncbi.nlm.nih.gov/pubmed/25701313
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s11095-015-1653-y
Etiketler: Etiketle
Etiket eklenmemiş, İlk siz ekleyin!

Benzer Materyaller